The ecosystem of evidence generation is rapidly changing. The available data that could be used to inform clinical research is becoming more decentralized and the need for more diverse participation is being encouraged. As research entities, pharmaceutical companies, and health systems seek to adapt to this shift, they also face significant obstacles at all phases of clinical research such as cost, regulation, ability to recruit diverse patients, and access to the right clinical trial resources. This panel will discuss our speakers' experiences and actions that could be done today to reduce this friction to enable clinical trials to accelerate the discovery and development of innovative therapeutics by harnessing the power of everyday healthcare.
Engage with us to help us rethink the historic evidence generation model and how to leverage data and technology to advance new medicine and therapies so patients get the treatment they need, and doctors get the information they need to deliver better care.
Martin Mendoza, PhD, Director of Health Equity, All of Us Research Program, National Institutes of Health
Gideon Scott Gordon, PhD, Senior Health Informatics Officer, Office of Strategic Programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Gillian Bartlett-Esquilant, PhD, Associate Dean for Population Health & Outcomes Research, Co-Director of the Translational Biosciences PhD and Professor of Family & Community Medicine, University of Missouri
David Hedges, PhD MS, Lead Data Scientist, Billings Clinic
Joseph Kliegman, PhD, Research Strategy Executive, Cerner (moderator)